#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cognitive disorder Focal segmental glomerulosclerosis Oesophageal adenocarcinoma Breast angiosarcoma Uterine leiomyosarcoma Macular telangiectasia Neurodegenerative disorder Cutaneous calcification Stress cardiomyopathy B precursor type acute leukaemia Palmar-plantar erythrodysaesthesia syndrome Anal cancer Diffuse large B-cell lymphoma recurrent Primary biliary cholangitis Bulbospinal muscular atrophy congenital More trials…

    Learn about Rare Diseases

    VEXAS syndrome – Treatment Lysosomal storage disorder Turner’s syndrome – Life with Disease Leiomyosarcoma metastatic – Life with Disease Hereditary ataxia – Trials in Disease Angelman’s syndrome – Diagnostics Breast angiosarcoma Rett syndrome – Life with Disease Haemophilia A without inhibitors – Diagnostics Leiomyosarcoma recurrent – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Siplizumab Neratinib Bi 1291583 Psilocybine Bio89-100 Efgartigimod Alfa VOTOPLAM Dextromethorphan Hydrobromide Epinephrine Bitartrate Azd5492 Mebufotenin Cortisone Agomelatine Trifluridine Taxanes Vismodegib Histamine Hydrochloride Bms-986340 Valoctocogene Roxaparvovec Cilgavimab More therapies…

    Learn about Your Condition

    Rett syndrome B-cell type acute leukaemia Glanzmann's disease Liver transplant Pneumonia Hereditary ataxia Synovial sarcoma Genital infection female Oesophageal cancer metastatic Chronic fatigue syndrome Oesophagogastroscopy Neuromuscular scoliosis Ligament operation Oropharyngeal cancer recurrent Anal cancer stage II More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Psoriatic arthropathy

  • Long-Term Safety and Efficacy of Zasocitinib in Adults with Active Psoriatic Arthritis

    Recruiting

    3 1
    Investigated Diseases:
    • Psoriatic arthropathy
    Investigated Drugs:
    • Zasocitinib
    Belgium Bulgaria Croatia Czechia Estonia France +7

  • Tulisokibart for Psoriatic Arthritis in Adults

    Recruiting

    2 1
    Investigated Diseases:
    • Psoriatic arthropathy
    Investigated Drugs:
    • Tulisokibart
    Germany Poland Spain

  • A study to evaluate the effectiveness and safety of JNJ-88545223 in people with active psoriatic arthritis

    Recruiting

    2 1
    Investigated Diseases:
    • Psoriatic arthropathy
    Czechia Germany Hungary Poland Spain

  • Study of Janus kinase inhibitor dose reduction in patients with rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis who have achieved low disease activity

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Axial spondyloarthritis
    • Rheumatic disorder
    • Rheumatoid arthritis
    Investigated Drugs:
    • Filgotinib
    • Baricitinib
    • Tofacitinib
    The Netherlands

  • Study on Lutikizumab and Risankizumab for Adults with Active Psoriatic Arthritis

    Recruiting

    2 1 1
    Investigated Diseases:
    • Psoriatic arthropathy
    Investigated Drugs:
    • Lutikizumab
    • Risankizumab
    Czechia France Hungary Poland

  • Study on the Effectiveness of Ixekizumab for Patients with Refractory Psoriatic Arthritis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Psoriatic arthropathy
    Investigated Drugs:
    • Ixekizumab
    Italy
1 2 3 … 8
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!